Recent developments in HIV protease inhibitor therapy

Antiviral Res. 1998 Jul;39(1):1-23. doi: 10.1016/s0166-3542(98)00011-4.
No abstract available

Publication types

  • Review

MeSH terms

  • Acquired Immunodeficiency Syndrome / drug therapy
  • Acquired Immunodeficiency Syndrome / metabolism
  • Acquired Immunodeficiency Syndrome / virology
  • Animals
  • Anti-HIV Agents / metabolism
  • Anti-HIV Agents / pharmacology*
  • Anti-HIV Agents / therapeutic use
  • Cytochrome P-450 CYP3A
  • Cytochrome P-450 Enzyme System / metabolism
  • Drug Resistance, Microbial / genetics
  • Drug Therapy, Combination
  • Genotype
  • HIV / drug effects*
  • HIV / genetics
  • HIV Protease Inhibitors / metabolism
  • HIV Protease Inhibitors / pharmacology*
  • HIV Protease Inhibitors / therapeutic use
  • Humans
  • Mixed Function Oxygenases / metabolism
  • Mutation / drug effects
  • Phenotype
  • RNA, Viral / blood
  • Rats
  • Viral Load

Substances

  • Anti-HIV Agents
  • HIV Protease Inhibitors
  • RNA, Viral
  • Cytochrome P-450 Enzyme System
  • Mixed Function Oxygenases
  • CYP3A protein, human
  • Cytochrome P-450 CYP3A